RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028
The global RNA analysis market size is projected to reach USD 9.9 billion by 2028 from 5.3 billion in 2023, at a CAGR of 13.4% during the forecast period. Factors such as the advancements in the field of transcriptomics studies, and the rising demand for reagents used in RNA analysis due to increased transcriptomics studies supporting the growth of therapeutics are driving the demand for RNA analysis products & services.
“The reagents/consumables segment accounted for the highest growth rate in the RNA analysis market, by product & service, during the forecast period”
In 2022, the reagents/consumables segment accounted for the highest growth rate. The product & service market is segmented into reagents/consumables, instruments, services, and software. Expanding applications of peptides in therapeutics, drug design, and gene synthesis and the growing number of ongoing research projects involving RNA analysis contributes to the segment's prominence in the RNA analysis market.
“Asia Pacific region is likely to grow at a faster pace.”
The RNA analysis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the RNA analysis market. The large share of the region is attributable to various factors such as the presence of leading players in the region paired with the continuing research activities of developing new genomic therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as rising government initiatives for generic medicines in the region, and the emergence of new market players in the RNA analysis market.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the RNA analysis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall RNA analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“The reagents/consumables segment accounted for the highest growth rate in the RNA analysis market, by product & service, during the forecast period”
In 2022, the reagents/consumables segment accounted for the highest growth rate. The product & service market is segmented into reagents/consumables, instruments, services, and software. Expanding applications of peptides in therapeutics, drug design, and gene synthesis and the growing number of ongoing research projects involving RNA analysis contributes to the segment's prominence in the RNA analysis market.
“Asia Pacific region is likely to grow at a faster pace.”
The RNA analysis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the RNA analysis market. The large share of the region is attributable to various factors such as the presence of leading players in the region paired with the continuing research activities of developing new genomic therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as rising government initiatives for generic medicines in the region, and the emergence of new market players in the RNA analysis market.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70%, and Demand Side - 30%
- By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
- Thermo Fisher Scientific, Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bio-Rad Laboratories, Inc. (US)
- Illumina, Inc. (US)
- Eurofins Scientific (Luxembourg)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Promega Corporation (US)
- QIAGEN N.V. (Germany)
- Standard BioTools (US)
- Sequentia Biotech SL (Spain)
- Acobiom (France)
- GenXPro GmbH (Germany)
- CD Genomics (US)
- Promega Corporation (US)
- Lexogen GmbH (Austria)
- Cenix BioScience GmbH (Germany)
- Takara Holdings, Inc. (Japan)
- bioMйrieux SA (France)
- LC Sciences LLC (US)
- Oxford Nanopore Technologies (UK)
- Zymo Research Corporation (US)
- GeneDx (US)
- Partek Incorporated (US)
- BGI Group (China)
This report provides a detailed picture of the RNA analysis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall RNA analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing demand for personalized medicine, Rising pharmaceutical and biotechnology R&D expenditure and government funding, and the Increasing applications of RNA sequencing in transcriptomics), restraints (High capital investments), opportunities (High growth opportunities in emerging markets, Increasing applications in toxicogenomics, Increasing focus on biomarker discovery, Rising focus on outsourcing), and challenges (Data management in transcriptomics research, Lack of effective bioinformatics tools, Dearth of skilled professionals.)
- Product & Service Development/Innovation: Detailed insights on newly launched products/services, and technological assessment of the RNA analysis market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the RNA analysis market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the RNA analysis market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players like Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), and among others in the RNA analysis market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 RNA ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 RNA ANALYSIS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2022)
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, TECHNOLOGY, APPLICATION, AND END USER)
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 8 RNA ANALYSIS MARKET: CAGR PROJECTIONS, 2023–2028
FIGURE 9 RNA ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF ECONOMIC RECESSION ON RNA ANALYSIS MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 11 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 RNA ANALYSIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 13 RNA ANALYSIS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 RNA ANALYSIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT: RNA ANALYSIS MARKET
4 PREMIUM INSIGHTS
4.1 RNA ANALYSIS MARKET OVERVIEW
FIGURE 16 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: RNA ANALYSIS MARKET SHARE, BY APPLICATION & COUNTRY (2022)
FIGURE 17 DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN RNA ANALYSIS MARKET IN 2022
4.3 RNA ANALYSIS MARKET SHARE, BY END USER, 2022
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 RNA ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN RNA ANALYSIS MARKET FROM 2023 TO 2028
4.5 RNA ANALYSIS MARKET, BY REGION (2023–2028)
FIGURE 20 NORTH AMERICA TO CONTINUE TO DOMINATE RNA ANALYSIS
MARKET UNTIL 2028
4.6 RNA ANALYSIS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 RNA ANALYSIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing demand for personalized medicine
FIGURE 23 PERSONALIZED MEDICINES APPROVED BY FDA, 2015–2022
5.2.1.2 Rising pharmaceutical and biotechnology R&D expenditure and government funding
FIGURE 24 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
5.2.1.3 Increasing applications of RNA sequencing in transcriptomics
5.2.2 RESTRAINTS
5.2.2.1 High capital investments
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging markets
5.2.3.2 Increasing applications in toxicogenomics
5.2.3.3 Increasing focus on biomarker discovery
5.2.3.4 Rising focus on outsourcing
5.2.4 CHALLENGES
5.2.4.1 Data management in transcriptomics research
5.2.4.2 Lack of effective bioinformatics tools
5.2.4.3 Dearth of skilled professionals
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS OF RNA ANALYSIS MARKET: RESEARCH AND MANUFACTURING PHASES CONTRIBUTE MAXIMUM VALUE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 26 RNA ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
TABLE 5 SUPPLY CHAIN ECOSYSTEM
5.7 PATENT ANALYSIS
FIGURE 27 PATENT APPLICATIONS FOR RNA ANALYSIS MARKET, JUNE 2012–JUNE 2023
5.8 LIST OF MAJOR PATENTS
5.9 TECHNOLOGY ANALYSIS
TABLE 6 COMPARISON OF MODERN RNA ANALYSIS METHODS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 RNA ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.11 REGULATORY ANALYSIS
5.11.1 REGULATIONS FOR RNA ANALYSIS PRODUCTS
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 KEY CONFERENCES AND EVENTS IN 2023
TABLE 11 RNA ANALYSIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RNA ANALYSIS PRODUCTS
5.13.2 BUYING CRITERIA
FIGURE 29 KEY BUYING CRITERIA FOR END USERS
6 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 12 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 REAGENTS/CONSUMABLES
6.2.1 REAGENTS/CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 13 RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY REGION,
2021–2028 (USD MILLION)
TABLE 14 NORTH AMERICA: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 EUROPE: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 ASIA PACIFIC: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 GROWING NEED FOR ACCURATE ANALYSIS TO DRIVE ADOPTION OF AUTOMATED INSTRUMENTS
TABLE 17 RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 NORTH AMERICA: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 EUROPE: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SOFTWARE
6.4.1 GROWING NEED FOR DATA MANAGEMENT AND QUALITY ENHANCEMENTS TO DRIVE DEMAND FOR SOFTWARE SOLUTIONS
TABLE 21 RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 NORTH AMERICA: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 EUROPE: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 ASIA PACIFIC: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SERVICES
6.5.1 INCREASING OUTSOURCING OF SERVICES TO PROPEL MARKET GROWTH
TABLE 25 RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 NORTH AMERICA: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 EUROPE: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 ASIA PACIFIC: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 RNA ANALYSIS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 29 RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 POLYMERASE CHAIN REACTION
7.2.1 ABILITY OF REAL-TIME PCR TO AID IN QUANTIFICATION OF LOW-COPY TRANSCRIPTS TO BOOST DEMAND
TABLE 30 RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SEQUENCING
7.3.1 ADVANCES IN NGS MULTIPLEXING CAPABILITIES TO AID MARKET GROWTH
TABLE 34 RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 MICROARRAYS
7.4.1 WIDE ADOPTION OF MICROARRAYS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
TABLE 38 RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 RNA INTERFERENCE
7.5.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT ADOPTION OF TECHNIQUE FOR DIAGNOSTICS AND THERAPEUTICS
TABLE 42 RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
8 RNA ANALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 46 RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 DRUG DISCOVERY
8.2.1 GROWING POPULARITY OF TARGETED SEQUENCING-BASED APPROACHES IN DRUG DISCOVERY TO BOOST MARKET
TABLE 47 RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 CLINICAL DIAGNOSTICS
8.3.1 GROWING ADOPTION OF TRANSCRIPTOMICS FOR LARGE-SCALE GENE EXPRESSION PROFILING OF ONCOLOGICAL DISORDERS TO FUEL GROWTH
TABLE 51 RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 TOXICOGENOMICS
8.4.1 GROWING FOCUS ON ADR STUDIES TO DRIVE ADOPTION OF TRANSCRIPTOMICS FOR SYSTEMIC TOXICOLOGY
TABLE 55 RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 COMPARATIVE TRANSCRIPTOMICS
8.5.1 WIDE ADOPTION OF TRANSCRIPTIONAL PROFILES TO STUDY EVOLUTION AMONG SPECIES TO PROPEL GROWTH
TABLE 59 RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
9 RNA ANALYSIS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 63 RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 INCREASING INVESTMENTS FOR ONCOLOGY THERAPEUTICS TO DRIVE USE OF OMICS TECHNOLOGIES IN PHARMA & BIOTECH COMPANIES
TABLE 64 RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 HOSPITALS & DIAGNOSTIC CENTERS
9.3.1 USE OF WHOLE-BLOOD TRANSCRIPTOME PROFILES FOR DISEASE DIAGNOSTICS TO FAVOR MARKET GROWTH
TABLE 68 RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL MARKET GROWTH
TABLE 72 RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 CONTRACT RESEARCH ORGANIZATIONS
9.5.1 GROWING OUTSOURCING OF SERVICES BY PHARMACEUTICAL COMPANIES FOR FASTER DRUG DISCOVERY TO AID MARKET GROWTH
TABLE 76 RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 RNA ANALYSIS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 80 RNA ANALYSIS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: RNA ANALYSIS MARKET SNAPSHOT
TABLE 81 NORTH AMERICA: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028(USD MILLION)
TABLE 82 NORTH AMERICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 84 NORTH AMERICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American RNA analysis market during forecast period
TABLE 86 US: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 87 US: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 88 US: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 89 US: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Improving funding and infrastructure for omics-based research to support market growth
TABLE 90 CANADA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 91 CANADA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 92 CANADA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 93 CANADA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 94 EUROPE: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 96 EUROPE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 97 EUROPE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 98 EUROPE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to hold largest share of European RNA analysis market during forecast period
TABLE 99 GERMANY: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 100 GERMANY: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 101 GERMANY: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 102 GERMANY: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising public and private funding for research to drive market growth
TABLE 103 UK: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 104 UK: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 105 UK: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 106 UK: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing government support for omics-based research to support market growth
TABLE 107 FRANCE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 108 FRANCE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 109 FRANCE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 110 FRANCE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Improving R&D expenditure and disease diagnostics to boost market
TABLE 111 ITALY: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 112 ITALY: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 113 ITALY: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 114 ITALY: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing collaborations for enhancing research to support market growth
TABLE 115 SPAIN: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 116 SPAIN: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 117 SPAIN: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 118 SPAIN: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 SWITZERLAND
10.3.6.1 Well-established pharmaceutical industry to drive market growth
TABLE 119 SWITZERLAND: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 120 SWITZERLAND: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 121 SWITZERLAND: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 122 SWITZERLAND: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 123 REST OF EUROPE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 124 REST OF EUROPE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 125 REST OF EUROPE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 126 REST OF EUROPE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4 EUROPE: RECESSION IMPACT
10.5 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: RNA ANALYSIS MARKET SNAPSHOT
TABLE 127 ASIA PACIFIC: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 ASIA PACIFIC: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 130 ASIA PACIFIC: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 CHINA
10.5.1.1 China to be fastest-growing market in Asia Pacific during forecast period
TABLE 132 CHINA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 133 CHINA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 134 CHINA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 135 CHINA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 JAPAN
10.5.2.1 Early adoption of technologically advanced products to drive market growth
TABLE 136 JAPAN: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 137 JAPAN: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 138 JAPAN: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 139 JAPAN: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 INDIA
10.5.3.1 Increasing pharmaceutical R&D spending and government funding for research to drive market growth
TABLE 140 INDIA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 141 INDIA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 142 INDIA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 143 INDIA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 REST OF ASIA PACIFIC
TABLE 144 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 145 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 146 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 147 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6 ASIA PACIFIC: RECESSION IMPACT
10.7 LATIN AMERICA
10.7.1 GROWTH IN PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH
TABLE 148 LATIN AMERICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 150 LATIN AMERICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 151 LATIN AMERICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.8 LATIN AMERICA: RECESSION IMPACT
10.9 MIDDLE EAST & AFRICA
10.9.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS TO DRIVE MARKET GROWTH
TABLE 152 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.10 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 32 RNA ANALYSIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
11.4 MARKET SHARE ANALYSIS
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
TABLE 156 RNA ANALYSIS MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS
FIGURE 35 RNA ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 COMPANY PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 157 COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN RNA ANALYSIS MARKET
11.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 158 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN RNA ANALYSIS MARKET
11.7 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
FIGURE 36 RNA ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/ SMES, 2022
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
11.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
TABLE 159 RNA ANALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 160 RNA ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 161 RNA ANALYSIS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020–JUNE 2023
11.9.2 DEALS
TABLE 162 RNA ANALYSIS MARKET: DEALS, JANUARY 2020–JUNE 2023
11.9.3 OTHER DEVELOPMENTS
TABLE 163 RNA ANALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 164 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
12.1.2 F. HOFFMANN-LA ROCHE LTD.
TABLE 165 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 38 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
12.1.3 BIO-RAD LABORATORIES, INC.
TABLE 166 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
12.1.4 ILLUMINA, INC.
TABLE 167 ILLUMINA, INC.: COMPANY OVERVIEW
FIGURE 40 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
12.1.5 EUROFINS SCIENTIFIC
TABLE 168 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
12.1.6 AGILENT TECHNOLOGIES, INC.
TABLE 169 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
12.1.7 CD GENOMICS
TABLE 170 CD GENOMICS: COMPANY OVERVIEW
12.1.8 PROMEGA CORPORATION
TABLE 171 PROMEGA CORPORATION: COMPANY OVERVIEW
12.1.9 QIAGEN N.V.
TABLE 172 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 43 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
12.1.10 DANAHER CORPORATION
TABLE 173 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
12.1.11 MERCK KGAA
TABLE 174 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2022)
12.1.12 STANDARD BIOTOOLS INC. (FLUIDIGM CORPORATION)
TABLE 175 STANDARD BIOTOOLS INC.: BUSINESS OVERVIEW
FIGURE 46 STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT (2022)
12.1.13 SEQUENTIA BIOTECH SL
TABLE 176 SEQUENTIA BIOTECH SL: BUSINESS OVERVIEW
12.1.14 ACOBIOM
TABLE 177 ACOBIOM: BUSINESS OVERVIEW
12.1.15 GENXPRO GMBH
TABLE 178 GENXPRO GMBH: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 LEXOGEN GMBH
12.2.2 CENIX BIOSCIENCE GMBH
12.2.3 TAKARA HOLDINGS INC.
12.2.4 BIOMЙRIEUX SA
12.2.5 LC SCIENCES LLC
12.2.6 OXFORD NANOPORE TECHNOLOGIES
12.2.7 ZYMO RESEARCH CORPORATION
12.2.8 GENEDX
12.2.9 PARTEK INCORPORATED
12.2.10 BGI GROUP
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 RNA ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 RNA ANALYSIS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2022)
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, TECHNOLOGY, APPLICATION, AND END USER)
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 8 RNA ANALYSIS MARKET: CAGR PROJECTIONS, 2023–2028
FIGURE 9 RNA ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF ECONOMIC RECESSION ON RNA ANALYSIS MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 11 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 RNA ANALYSIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 13 RNA ANALYSIS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 RNA ANALYSIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT: RNA ANALYSIS MARKET
4 PREMIUM INSIGHTS
4.1 RNA ANALYSIS MARKET OVERVIEW
FIGURE 16 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: RNA ANALYSIS MARKET SHARE, BY APPLICATION & COUNTRY (2022)
FIGURE 17 DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN RNA ANALYSIS MARKET IN 2022
4.3 RNA ANALYSIS MARKET SHARE, BY END USER, 2022
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 RNA ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN RNA ANALYSIS MARKET FROM 2023 TO 2028
4.5 RNA ANALYSIS MARKET, BY REGION (2023–2028)
FIGURE 20 NORTH AMERICA TO CONTINUE TO DOMINATE RNA ANALYSIS
MARKET UNTIL 2028
4.6 RNA ANALYSIS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 RNA ANALYSIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing demand for personalized medicine
FIGURE 23 PERSONALIZED MEDICINES APPROVED BY FDA, 2015–2022
5.2.1.2 Rising pharmaceutical and biotechnology R&D expenditure and government funding
FIGURE 24 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
5.2.1.3 Increasing applications of RNA sequencing in transcriptomics
5.2.2 RESTRAINTS
5.2.2.1 High capital investments
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging markets
5.2.3.2 Increasing applications in toxicogenomics
5.2.3.3 Increasing focus on biomarker discovery
5.2.3.4 Rising focus on outsourcing
5.2.4 CHALLENGES
5.2.4.1 Data management in transcriptomics research
5.2.4.2 Lack of effective bioinformatics tools
5.2.4.3 Dearth of skilled professionals
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS OF RNA ANALYSIS MARKET: RESEARCH AND MANUFACTURING PHASES CONTRIBUTE MAXIMUM VALUE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 26 RNA ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
TABLE 5 SUPPLY CHAIN ECOSYSTEM
5.7 PATENT ANALYSIS
FIGURE 27 PATENT APPLICATIONS FOR RNA ANALYSIS MARKET, JUNE 2012–JUNE 2023
5.8 LIST OF MAJOR PATENTS
5.9 TECHNOLOGY ANALYSIS
TABLE 6 COMPARISON OF MODERN RNA ANALYSIS METHODS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 RNA ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.11 REGULATORY ANALYSIS
5.11.1 REGULATIONS FOR RNA ANALYSIS PRODUCTS
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 KEY CONFERENCES AND EVENTS IN 2023
TABLE 11 RNA ANALYSIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RNA ANALYSIS PRODUCTS
5.13.2 BUYING CRITERIA
FIGURE 29 KEY BUYING CRITERIA FOR END USERS
6 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 12 RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 REAGENTS/CONSUMABLES
6.2.1 REAGENTS/CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 13 RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY REGION,
2021–2028 (USD MILLION)
TABLE 14 NORTH AMERICA: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 EUROPE: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 ASIA PACIFIC: RNA ANALYSIS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 GROWING NEED FOR ACCURATE ANALYSIS TO DRIVE ADOPTION OF AUTOMATED INSTRUMENTS
TABLE 17 RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 NORTH AMERICA: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 EUROPE: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: RNA ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SOFTWARE
6.4.1 GROWING NEED FOR DATA MANAGEMENT AND QUALITY ENHANCEMENTS TO DRIVE DEMAND FOR SOFTWARE SOLUTIONS
TABLE 21 RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 NORTH AMERICA: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 EUROPE: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 ASIA PACIFIC: RNA ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SERVICES
6.5.1 INCREASING OUTSOURCING OF SERVICES TO PROPEL MARKET GROWTH
TABLE 25 RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 NORTH AMERICA: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 EUROPE: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 ASIA PACIFIC: RNA ANALYSIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 RNA ANALYSIS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 29 RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 POLYMERASE CHAIN REACTION
7.2.1 ABILITY OF REAL-TIME PCR TO AID IN QUANTIFICATION OF LOW-COPY TRANSCRIPTS TO BOOST DEMAND
TABLE 30 RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: RNA ANALYSIS MARKET FOR PCR TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SEQUENCING
7.3.1 ADVANCES IN NGS MULTIPLEXING CAPABILITIES TO AID MARKET GROWTH
TABLE 34 RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: RNA ANALYSIS MARKET FOR SEQUENCING TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 MICROARRAYS
7.4.1 WIDE ADOPTION OF MICROARRAYS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
TABLE 38 RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: RNA ANALYSIS MARKET FOR MICROARRAY TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 RNA INTERFERENCE
7.5.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT ADOPTION OF TECHNIQUE FOR DIAGNOSTICS AND THERAPEUTICS
TABLE 42 RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: RNA ANALYSIS MARKET FOR RNA INTERFERENCE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
8 RNA ANALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 46 RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 DRUG DISCOVERY
8.2.1 GROWING POPULARITY OF TARGETED SEQUENCING-BASED APPROACHES IN DRUG DISCOVERY TO BOOST MARKET
TABLE 47 RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: RNA ANALYSIS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 CLINICAL DIAGNOSTICS
8.3.1 GROWING ADOPTION OF TRANSCRIPTOMICS FOR LARGE-SCALE GENE EXPRESSION PROFILING OF ONCOLOGICAL DISORDERS TO FUEL GROWTH
TABLE 51 RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: RNA ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 TOXICOGENOMICS
8.4.1 GROWING FOCUS ON ADR STUDIES TO DRIVE ADOPTION OF TRANSCRIPTOMICS FOR SYSTEMIC TOXICOLOGY
TABLE 55 RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: RNA ANALYSIS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 COMPARATIVE TRANSCRIPTOMICS
8.5.1 WIDE ADOPTION OF TRANSCRIPTIONAL PROFILES TO STUDY EVOLUTION AMONG SPECIES TO PROPEL GROWTH
TABLE 59 RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: RNA ANALYSIS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
9 RNA ANALYSIS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 63 RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 INCREASING INVESTMENTS FOR ONCOLOGY THERAPEUTICS TO DRIVE USE OF OMICS TECHNOLOGIES IN PHARMA & BIOTECH COMPANIES
TABLE 64 RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: RNA ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 HOSPITALS & DIAGNOSTIC CENTERS
9.3.1 USE OF WHOLE-BLOOD TRANSCRIPTOME PROFILES FOR DISEASE DIAGNOSTICS TO FAVOR MARKET GROWTH
TABLE 68 RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: RNA ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL MARKET GROWTH
TABLE 72 RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: RNA ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 CONTRACT RESEARCH ORGANIZATIONS
9.5.1 GROWING OUTSOURCING OF SERVICES BY PHARMACEUTICAL COMPANIES FOR FASTER DRUG DISCOVERY TO AID MARKET GROWTH
TABLE 76 RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: RNA ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 RNA ANALYSIS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 80 RNA ANALYSIS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: RNA ANALYSIS MARKET SNAPSHOT
TABLE 81 NORTH AMERICA: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028(USD MILLION)
TABLE 82 NORTH AMERICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 84 NORTH AMERICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American RNA analysis market during forecast period
TABLE 86 US: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 87 US: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 88 US: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 89 US: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Improving funding and infrastructure for omics-based research to support market growth
TABLE 90 CANADA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 91 CANADA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 92 CANADA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 93 CANADA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 94 EUROPE: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 96 EUROPE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 97 EUROPE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 98 EUROPE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to hold largest share of European RNA analysis market during forecast period
TABLE 99 GERMANY: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 100 GERMANY: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 101 GERMANY: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 102 GERMANY: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising public and private funding for research to drive market growth
TABLE 103 UK: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 104 UK: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 105 UK: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 106 UK: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing government support for omics-based research to support market growth
TABLE 107 FRANCE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 108 FRANCE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 109 FRANCE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 110 FRANCE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Improving R&D expenditure and disease diagnostics to boost market
TABLE 111 ITALY: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 112 ITALY: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 113 ITALY: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 114 ITALY: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing collaborations for enhancing research to support market growth
TABLE 115 SPAIN: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 116 SPAIN: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 117 SPAIN: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 118 SPAIN: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 SWITZERLAND
10.3.6.1 Well-established pharmaceutical industry to drive market growth
TABLE 119 SWITZERLAND: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 120 SWITZERLAND: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 121 SWITZERLAND: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 122 SWITZERLAND: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 123 REST OF EUROPE: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 124 REST OF EUROPE: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 125 REST OF EUROPE: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 126 REST OF EUROPE: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4 EUROPE: RECESSION IMPACT
10.5 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: RNA ANALYSIS MARKET SNAPSHOT
TABLE 127 ASIA PACIFIC: RNA ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 ASIA PACIFIC: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 130 ASIA PACIFIC: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 CHINA
10.5.1.1 China to be fastest-growing market in Asia Pacific during forecast period
TABLE 132 CHINA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 133 CHINA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 134 CHINA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 135 CHINA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 JAPAN
10.5.2.1 Early adoption of technologically advanced products to drive market growth
TABLE 136 JAPAN: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 137 JAPAN: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 138 JAPAN: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 139 JAPAN: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 INDIA
10.5.3.1 Increasing pharmaceutical R&D spending and government funding for research to drive market growth
TABLE 140 INDIA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 141 INDIA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 142 INDIA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 143 INDIA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 REST OF ASIA PACIFIC
TABLE 144 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 145 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 146 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 147 REST OF ASIA PACIFIC: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6 ASIA PACIFIC: RECESSION IMPACT
10.7 LATIN AMERICA
10.7.1 GROWTH IN PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH
TABLE 148 LATIN AMERICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 150 LATIN AMERICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 151 LATIN AMERICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.8 LATIN AMERICA: RECESSION IMPACT
10.9 MIDDLE EAST & AFRICA
10.9.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS TO DRIVE MARKET GROWTH
TABLE 152 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: RNA ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.10 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 32 RNA ANALYSIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
11.4 MARKET SHARE ANALYSIS
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
TABLE 156 RNA ANALYSIS MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS
FIGURE 35 RNA ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 COMPANY PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 157 COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN RNA ANALYSIS MARKET
11.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 158 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN RNA ANALYSIS MARKET
11.7 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
FIGURE 36 RNA ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/ SMES, 2022
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
11.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
TABLE 159 RNA ANALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 160 RNA ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 161 RNA ANALYSIS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020–JUNE 2023
11.9.2 DEALS
TABLE 162 RNA ANALYSIS MARKET: DEALS, JANUARY 2020–JUNE 2023
11.9.3 OTHER DEVELOPMENTS
TABLE 163 RNA ANALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 164 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
12.1.2 F. HOFFMANN-LA ROCHE LTD.
TABLE 165 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 38 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
12.1.3 BIO-RAD LABORATORIES, INC.
TABLE 166 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
12.1.4 ILLUMINA, INC.
TABLE 167 ILLUMINA, INC.: COMPANY OVERVIEW
FIGURE 40 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
12.1.5 EUROFINS SCIENTIFIC
TABLE 168 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
12.1.6 AGILENT TECHNOLOGIES, INC.
TABLE 169 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
12.1.7 CD GENOMICS
TABLE 170 CD GENOMICS: COMPANY OVERVIEW
12.1.8 PROMEGA CORPORATION
TABLE 171 PROMEGA CORPORATION: COMPANY OVERVIEW
12.1.9 QIAGEN N.V.
TABLE 172 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 43 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
12.1.10 DANAHER CORPORATION
TABLE 173 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
12.1.11 MERCK KGAA
TABLE 174 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2022)
12.1.12 STANDARD BIOTOOLS INC. (FLUIDIGM CORPORATION)
TABLE 175 STANDARD BIOTOOLS INC.: BUSINESS OVERVIEW
FIGURE 46 STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT (2022)
12.1.13 SEQUENTIA BIOTECH SL
TABLE 176 SEQUENTIA BIOTECH SL: BUSINESS OVERVIEW
12.1.14 ACOBIOM
TABLE 177 ACOBIOM: BUSINESS OVERVIEW
12.1.15 GENXPRO GMBH
TABLE 178 GENXPRO GMBH: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 LEXOGEN GMBH
12.2.2 CENIX BIOSCIENCE GMBH
12.2.3 TAKARA HOLDINGS INC.
12.2.4 BIOMЙRIEUX SA
12.2.5 LC SCIENCES LLC
12.2.6 OXFORD NANOPORE TECHNOLOGIES
12.2.7 ZYMO RESEARCH CORPORATION
12.2.8 GENEDX
12.2.9 PARTEK INCORPORATED
12.2.10 BGI GROUP
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
